The 20 Best Acute Myeloblastic Leukemia without Maturation Doctors in New Jersey, US

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.

Aziz Nazha is a Hematologist and a Hematologist Oncology provider in Cherry Hill, New Jersey. Dr. Nazha is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Nazha is currently accepting new patients.

Joanne Filicko is an Oncologist and a Transplant Surgeon in Cherry Hill, New Jersey. Dr. Filicko is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Multiple Myeloma, and Bone Marrow Transplant. Dr. Filicko is currently accepting new patients.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

James Mccloskey is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Mccloskey is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Colonoscopy.

Michele Donato is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Donato is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Multiple Myeloma, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy.

Jamie Koprivnikar is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Koprivnikar is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Endoscopy.

Sukhdeep Kaur is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Kaur is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Colonoscopy.

Katherine Linder is a Hematologist and an Oncologist in Hackensack, New Jersey. Dr. Linder is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Aplastic Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Lori Leslie is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Leslie is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Lymphadenectomy.

Christina Cho is a Hematologist in Hackensack, New Jersey. Dr. Cho is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Colonoscopy.

Kelly Fitzpatrick is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Fitzpatrick is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Primary Mediastinal B-Cell Lymphoma (PMBCL), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Hereditary Resistance to Anti-Vitamin K, and Bone Marrow Aspiration.

David Vesole is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Vesole is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant.

Tatyana Feldman is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Feldman is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Scott Rowley is a Hematologist in Hackensack, New Jersey. Dr. Rowley is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Colonoscopy.

Raunaq Bhatt is a primary care provider, practicing in Hospital Medicine in Morristown, New Jersey. Dr. Bhatt is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Gastrostomy.

Roger Strair is a Hematologist Oncology provider in Voorhees, New Jersey. Dr. Strair has been practicing medicine for over 45 years and is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Usman Shah is a Hematologist and an Oncologist in Summit, New Jersey. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Neil S. Nimkar, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, he is trained in all malignancies and blood disorders. His clinical interests include anemia; hematology - WBC disorders; breast, colorectal, gastrointestinal, head and neck, and urological cancer (GU); leukemia and lymphoma. Dr. Nimkar strives to provide care individualized to the needs of each patient, while incorporating the most up-to-date knowledge and using precision medicine approach in treating patients. He takes pride in delivering the highest quality of patient care.After earning his medical degree at Ross University School of Medicine in Barbados, Dr. Nimkar completed his internal medicine residency at New York-Presbyterian Brooklyn Methodist Hospital in Brooklyn, NY, where he also performed his hematology-oncology fellowship. He received awards for excellence in clinical documentation as a best patient advocate, best ambulatory resident and as a wellness warrior. Dr. Nimkar joined ACOHA in 2021 following his fellowship training.In addition to English, Dr. Nimkar is fluent in Hindi and Gujarati. He has been published several times in peer-reviewed medical journals. His recent published research includes immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction, and he conducted an extensive study analyzing causes for the overtransfusion of blood products of patients. Dr. Nimkar is a participating provider of the Atlantic Accountable Care Organization. Dr. Nimkar is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Familial Colorectal Cancer, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Melanoma.